GB9914650D0 - Chimeric proteins mediating targeted apoptosis - Google Patents

Chimeric proteins mediating targeted apoptosis

Info

Publication number
GB9914650D0
GB9914650D0 GBGB9914650.8A GB9914650A GB9914650D0 GB 9914650 D0 GB9914650 D0 GB 9914650D0 GB 9914650 A GB9914650 A GB 9914650A GB 9914650 D0 GB9914650 D0 GB 9914650D0
Authority
GB
United Kingdom
Prior art keywords
chimeric proteins
proteins mediating
targeted apoptosis
mediating targeted
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914650.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANGYOGENE PHARMACEUTICALS Ltd
Original Assignee
ANGYOGENE PHARMACEUTICALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANGYOGENE PHARMACEUTICALS Ltd filed Critical ANGYOGENE PHARMACEUTICALS Ltd
Priority to GBGB9914650.8A priority Critical patent/GB9914650D0/en
Publication of GB9914650D0 publication Critical patent/GB9914650D0/en
Priority to EP00940615A priority patent/EP1192262A2/en
Priority to AU55527/00A priority patent/AU5552700A/en
Priority to CA002377489A priority patent/CA2377489A1/en
Priority to PCT/GB2000/002449 priority patent/WO2001000854A2/en
Ceased legal-status Critical Current

Links

GBGB9914650.8A 1999-06-24 1999-06-24 Chimeric proteins mediating targeted apoptosis Ceased GB9914650D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9914650.8A GB9914650D0 (en) 1999-06-24 1999-06-24 Chimeric proteins mediating targeted apoptosis
EP00940615A EP1192262A2 (en) 1999-06-24 2000-06-26 Chimeric proteins mediating targeted apoptosis
AU55527/00A AU5552700A (en) 1999-06-24 2000-06-26 Chimeric proteins mediating targeted apoptosis
CA002377489A CA2377489A1 (en) 1999-06-24 2000-06-26 Chimeric proteins mediating targeted apoptosis
PCT/GB2000/002449 WO2001000854A2 (en) 1999-06-24 2000-06-26 Chimeric proteins mediating targeted apoptosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914650.8A GB9914650D0 (en) 1999-06-24 1999-06-24 Chimeric proteins mediating targeted apoptosis

Publications (1)

Publication Number Publication Date
GB9914650D0 true GB9914650D0 (en) 1999-08-25

Family

ID=10855886

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914650.8A Ceased GB9914650D0 (en) 1999-06-24 1999-06-24 Chimeric proteins mediating targeted apoptosis

Country Status (5)

Country Link
EP (1) EP1192262A2 (en)
AU (1) AU5552700A (en)
CA (1) CA2377489A1 (en)
GB (1) GB9914650D0 (en)
WO (1) WO2001000854A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6734017B2 (en) * 2001-09-28 2004-05-11 Isis Pharmaceuticals, Inc. Antisense modulation of vascular endothelial growth factor receptor-2 expression
CA2670790A1 (en) 2006-11-28 2008-06-05 Ghc Research Development Corporation Polypeptides comprising fas activation and nkg2d-ligand domains
WO2011138414A1 (en) * 2010-05-05 2011-11-10 Addex Pharma Sa Methods and tools for screening agents exhibiting an activity on receptors of the tumor necrosis factor receptor superfamily
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
GB201506223D0 (en) * 2015-04-13 2015-05-27 Ucl Business Plc Chimeric protein
US11066465B2 (en) 2015-12-30 2021-07-20 Kodiak Sciences Inc. Antibodies and conjugates thereof
WO2021072265A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861151A (en) * 1991-12-20 1999-01-19 Bristol-Myers Squibb Co Soluble fusion molecules with binding specificity for cell adhesion molecules
JPH09503645A (en) * 1993-07-16 1997-04-15 ザ・ボード・オブ・トラスティーズ・オブ・ザ・リランド・スタンフォード・ジュニアー・ユニバーシティ Controlled apoptosis

Also Published As

Publication number Publication date
WO2001000854A3 (en) 2001-07-05
CA2377489A1 (en) 2001-01-04
WO2001000854A2 (en) 2001-01-04
EP1192262A2 (en) 2002-04-03
AU5552700A (en) 2001-01-31

Similar Documents

Publication Publication Date Title
IL145998A0 (en) Substituted heterocycle fused gamma-carbolines
AU2001241100A1 (en) Polypeptide inducing apoptosis
AU2002305935A1 (en) Chimeric metal-binding peptides with nuclease activity
GB9913437D0 (en) Fusion proteins
GB9914650D0 (en) Chimeric proteins mediating targeted apoptosis
GB9921318D0 (en) Chimeric molecules
AU5446499A (en) Apoptosis inducing agents
AU6983000A (en) Chimeric proteins
AU7353500A (en) Apoptosis proteins
GB9927681D0 (en) Protein
PL349973A1 (en) Star-to-triangle switching element
EP1146053A4 (en) Meg-4 protein
EP1209231A4 (en) Meg-1 protein
GB9925763D0 (en) Ploughshare assembly
GB9924060D0 (en) VIP54 protein
EP1188828A4 (en) Reg-binding protein
GB0028305D0 (en) Liquid application means
GB9910326D0 (en) Ploughs
CZ20003877A3 (en) Heater
GB9923153D0 (en) Chimeric antibodies
GB9930101D0 (en) Energised liquid
GB9902419D0 (en) Protein domain
GB2356888B (en) Former element
GR990200160U (en) Geyser element
CA88465S (en) Boîte de montre

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)